Guangdong is a large province of traditional Chinese medicine manufacturing, which has many good effects. The people like to use traditional medicines to reduce fever, relieve cough, fight viruses and treat colds. In order to implement the relevant deployment of the State Drug Administration, the provincial party committee and the provincial government on ensuring the quality and safety of drugs used by people infected with COVID-19 and the supply of drugs, the Guangdong Provincial Drug Administration, referring to the actual situation of drug use in this round of epidemic, formulated and released the Catalogue of Key Drug Use Supervision for People Infected with COVID-19 in Guangdong Province in combination with the local climate characteristics, drug use habits and the actual production capacity of key drug manufacturers in product categories. According to the relevant person in charge of Guangdong Drug Administration, as of December 21, Guangdong had one manufacturer of Huashi Baidu Granules, with a daily output of 1.66 million bags; Three ibuprofen preparation manufacturers under key monitoring, with daily output of 12.98 million tablets/capsule; The daily output of the three key acetaminophen preparation manufacturers reached 6 million tablets/day. In addition to the above varieties, the large varieties listed in the key regulatory catalogue by Guangdong Drug Administration, such as Ganmaoling Granules, 2.5 million pieces of anti-virus oral liquid, 3.9 million bags of Banlangen Granules, 2.6 million bags of Xiaochaihu Granules and 7.2 million bags of Acafenol Powder, are in sufficient supply and can fully meet the drug demand of the people. For the varieties and drug manufacturers listed in the key regulatory catalogue, Guangdong Drug Administration will comprehensively use supervision and inspection, sampling, monitoring and other regulatory means to do a solid job in the supervision of the varieties and enterprises listed in the catalogue, strengthen the investigation and punishment of illegal acts, and timely discover and eliminate potential risks. Urge enterprises to implement the main responsibility of quality, improve the quality management system throughout the life cycle, organize production in strict accordance with the drug production quality management specifications, strengthen the quality traceability management throughout the process, and strictly observe the bottom line of drug quality safety. At the same time, it will give full play to the role of drug retail enterprises as the terminal drug channel, make use of the professional advantages of licensed pharmacists and other pharmaceutical technicians, effectively strengthen the guidance of public drug use, guide consumers to use drugs rationally, purchase drugs rationally, avoid excessive consumption of drugs, blindly hoard drugs, and create a good atmosphere for scientific drug purchase and rational drug use in the whole society. Guangdong Provincial Drug Administration reminds citizens to prevent and control scientifically, prepare medicine for the symptoms, not blindly hoard medicine, and be the first responsible person for their own health. (Liu Xinshe)